论文部分内容阅读
目的:观察头孢菌素联合鱼腥草注射液治疗老年慢性支气管炎的临床疗效及安全性。方法:按照随机原则将76例老年慢性支气管炎患者分成两组,在常规治疗的基础上,其中对照组76人采用头孢菌素治疗,治疗组患者在对照组治疗的基础上给予鱼腥草注射液治疗,对两组临床费用、住院时间和临床疗效进行评价。结果:治疗组和对照组的住院时间分别为(26.0±4.2)d和(32.4±3.4)d,住院时间差异有显著性(P<0.05);治疗组的医疗费用为(10477±1273.2)元,对照组医疗费用为(12790±892.3)元,两组医疗费用差异有显著性(P<0.05);治疗组临床有效率为83.4%,显著高于对照组的临床有效率(70.8%)(P<0.05)。结论:头孢菌素联合鱼腥草注射液治疗老年慢性支气管炎的临床疗效确切,值得临床推广。
Objective: To observe the clinical efficacy and safety of cephalosporin combined with Houttuynia injection in the treatment of senile chronic bronchitis. Methods: According to the random principle, 76 elderly patients with chronic bronchitis were divided into two groups. On the basis of routine treatment, 76 of the control group were treated with cephalosporin. The patients in the treatment group were given Houttuynia Cordata injection on the basis of the treatment of the control group Liquid treatment, the two groups of clinical costs, hospitalization time and clinical efficacy evaluation. Results: The hospitalization time was (26.0 ± 4.2) days and (32.4 ± 3.4) days respectively in the treatment group and the control group, and there was significant difference in hospitalization time (P <0.05). The medical cost of the treatment group was (10477 ± 1273.2) yuan (12790 ± 892.3) yuan in the control group, the difference was significant (P <0.05) between the two groups; the clinical effective rate in the treatment group was 83.4%, which was significantly higher than that in the control group (70.8%) P <0.05). Conclusion: The clinical efficacy of cephalosporin combined with Houttuynia injection in the treatment of senile chronic bronchitis is accurate and worthy of clinical promotion.